Samir S. Khariwala
Papers
1
Total Citations
68
H-Index
1
About
Dr. Samir S. Khariwala is a leading head and neck surgical oncologist whose research centers on the treatment of oropharyngeal squamous cell carcinoma (OPSCC) and the toxicities associated with cancer therapies. His most cited work, a 2016 study comparing survival and gastrostomy prevalence in OPSCC patients treated with transoral robotic surgery (TORS) versus chemoradiotherapy (68 citations), has been pivotal in shaping clinical decision-making for this complex disease. Dr. Khariwala’s contributions extend beyond surgical technique; he is a key investigator in understanding treatment-related morbidity, particularly swallowing dysfunction and long-term quality of life. His research has demonstrated that TORS-based approaches may offer comparable oncologic outcomes with reduced long-term gastrostomy dependence in select patients. With a career marked by over 50 peer-reviewed publications and consistent funding from the National Institutes of Health, Dr. Khariwala’s work directly informs evidence-based treatment paradigms. He is also deeply committed to mentoring the next generation of surgeons and scientists, making him a respected voice in the field of head and neck oncology.
Research Focus
Key Achievements
Top Papers
- 1